Chemoinformaics analysis of cycloart-24-en-beta,25-diol
| Molecular Weight | 442.728 | nRot | 5 |
| Heavy Atom Molecular Weight | 392.328 | nRig | 23 |
| Exact Molecular Weight | 442.381 | nRing | 5 |
| Solubility: LogS | -4.932 | nHRing | 0 |
| Solubility: LogP | 6.467 | No. of Aliphatic Rings | 5 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 5 |
| Atoms Count | 82 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 32 | No. of Aromatic Carbocycles | 0 |
| nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 5 |
| No. of Hydrogen atom | 50 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 30 | No. of Saturated Rings | 5 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 2 | No. of Arom Bond | 0 |
| nHA | 2 | APOL | 85.0436 |
| nHD | 2 | BPOL | 50.1604 |
| QED | 0.444 |
| Synth | 5.572 |
| Natural Product Likeliness | 3.396 |
| NR-PPAR-gamma | 0.42 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Rejected |
| Pgp-inh | 0.057 |
| Pgp-sub | 0.001 |
| HIA | 0.004 |
| CACO-2 | -4.974 |
| MDCK | 0.000015 |
| BBB | 0.213 |
| PPB | 0.954047 |
| VDSS | 1.232 |
| FU | 0.0270766 |
| CYP1A2-inh | 0.024 |
| CYP1A2-sub | 0.282 |
| CYP2c19-inh | 0.052 |
| CYP2c19-sub | 0.937 |
| CYP2c9-inh | 0.196 |
| CYP2c9-sub | 0.264 |
| CYP2d6-inh | 0.019 |
| CYP2d6-sub | 0.637 |
| CYP3a4-inh | 0.8 |
| CYP3a4-sub | 0.673 |
| CL | 8.268 |
| T12 | 0.072 |
| hERG | 0.186 |
| Ames | 0.003 |
| ROA | 0.543 |
| SkinSen | 0.934 |
| Carcinogencity | 0.063 |
| EI | 0.073 |
| Respiratory | 0.927 |
| NR-Aromatase | 0.676 |
| Antiviral | No |
| Prediction | 0.727541 |